Assessment of cardiovascular risk in patients with gout and nonalcoholic fatty liver disease

Authors

  • S. I. Smiyan Ternopil State Medical University,
  • S. V. Danchak Ternopil State Medical University,

DOI:

https://doi.org/10.14739/2310-1237.2015.3.55609

Keywords:

Gout, Liver Diseases, Cardiovascular Diseases

Abstract

Aim. Cardiovascular diseases are observed more frequently in patients with gout as compared to other rheumatologic pathologies.

Methods and results. 120 patients with gout were examined to study the frequency of cardiovascular risk in patients combined with nonalcoholic fatty liver disease (NAFLD). To determine cardiovascular risk SCORE chart was used, the diagnosis of nonalcoholic fatty liver disease was confirmed by share wave elastography.

Conclusion. In patients with gout and nonalcoholic fatty liver disease there is increasing of cardiovascular risk level, low cardiovascular risk is found in 16.2%, moderate in 25.0%, high in 19.1% and very high risk in 39.7% of cases. Among patients without associated liver injury another tendency is observed, particularly low risk was found in 32.7%, moderate in 40.4%, high in 17.3% and very high risk in 9.6% of cases. Risk factors for cardiovascular disease in patients with gout combined with nonalcoholic fatty liver disease include hypertension, hypercholesterolemia, hyperuricemia, smoking, an increase of patients’ age, body mass index. The level of hyperuricemia was significantly (p <0.01) higher among patients with nonalcoholic fatty liver disease patients and increased together with increasing risk of cardiovascular catastrophes.

References

Meek, I. L., Picavet, H. S., Vonkeman, H. E., Verschuren, W. M., & van de Laar, M. A. (2013). Increased cardiovascular risk factors in different rheumatic diseases compared with the general population. Rheumatology (Oxford), 52, 210–216. doi: 10.1093/rheumatology/kes194.

Roddy, E., & Doherty, M. (2010). Epidemiology of gout Arth. Res. Ther, 12(223), 1–11. doi: 10.1186/ar3199.

Bhatia, L. S. (2012). Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur. Heart J, 33, 1190–1200. doi: 10.1093/eurheartj/ehr453.

Kolesnikova, O. V., Babak, O. Ya., Solomentseva, T. A., Kurinna, O. G., & Sytnyk, K. O. (2013). Osoblyvosti vuhlevodnoho ta lipidnoho obminu u khvorykh na nealkoholnu zhyrovu khvorobu pechinky zalezhno vid stupenia kardiovaskuliarnoho ryzyku [Carbohydrate and lipid metabolism features in patients with nonalcoholic fatty liver disease, depending on the degree of cardiovascular risk]. Suchasna hastroenterolohiia, 6, 7–12. [in Ukrainian].

Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., et al. (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology, 55(6), 2005–23. doi: 10.1002/hep.25762.

Sung, K. C., Wild, S. H., Kwag H. J., & Byrne, C. D. (2012). Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people. Diabetes Care, 35, 2359–2364. doi: 10.2337/dc12-0515.

Chen, S. H., He, F., Zhou, H. L., Wu, H. R., Xia, C., & Li, Y. M. (2011). Relationship between nonalcoholic fatty liver disease and metabolic syndrome. J. Dig. Dis, 12, 125–130. doi: 10.1111/j.1751-2980.2011.00487.x.

Zhang, Y., Hong, Q., Huang, Z., Xue, P., Lv, Y., & Fu, B. (2014). ALDR enhanced endothelial injury in hyperuricemia screened using SILAC. Cell. Physiol. Biochem, 33(2), 479–490. doi: 10.1159/000358628.

Stepanova, M., & Younossi, Z. M. (2012). Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clin. Gastroenterol. Hepatol, 10(6), 646–650. doi: 10.1016/j.cgh.2011.12.039.

Targher, G., Zoppini, G., & Day, C. P. (2011). Risk of all-cause and cardiovascular mortality in patients with chronic liver disease. Gut, 60, 1602–1603. doi:10.1136/gut.2010.230656.

Downloads

How to Cite

1.
Smiyan SI, Danchak SV. Assessment of cardiovascular risk in patients with gout and nonalcoholic fatty liver disease. Pathologia [Internet]. 2015Dec.18 [cited 2024Nov.22];(3). Available from: http://pat.zsmu.edu.ua/article/view/55609

Issue

No. 3 (2015)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Лицензия Creative Commons
    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).